Granules India Q4 results: Paracetamol, Ibuprofen maker's profit misses analysts' estimates; board announces 150% dividend
Granules India Q4 results, dividend news: Granules India — a Hyderabad-based pharma company that makes Paracetamol and Ibuprofen — reported a net profit of Rs 119.6 crore for the quarter ended March 2023, missing analysts' estimates. Granules India's board recommended a dividend of 150 per cent.
Granules India reported a quarterly net profit that fell short of Street estimates. | Image: granulesindia.com